StockData
Denali Therapeutics Inc. logo

Denali Therapeutics Inc. (DNLI) dividend history

DNLINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$18.00−0.08 (-0.44%)

Close on Nov 17, 2026Market cap $2.88BP/E –Yield –

Dividends

Denali Therapeutics has not reported a dividend

No dividend per share appears in Denali Therapeutics's annual filings since fiscal 2015.

See a number that looks wrong?